Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Ginkgolide K potentiates the protective effect of ketamine against intestinal ischemia/reperfusion injury by modulating NF-κB/ERK/JNK signaling pathway

Weina Zhu¹, Zhili Zhao², Xiongtao Liu³, Xiumei Ni³, Xiaoming Lei³, Xiaoying Li³, Rui Deng³, Liyan Zhao³

¹Department of anesthesiology, PLA Air Force 986 Hospital, Xi 'an, Shaanxi 710054; ²Department of orthopedics, PLA Air Force 986 Hospital, Xi 'an, Shaanxi 710054; ³Department of anesthesiology, The Second Affiliated Hospital of Xi'an Jiaotong University (Xibei Hospital), Xi 'an, Shaanxi 710004, China.

For correspondence:- Liyan Zhao Email: 1104924271@qq.com Tel:+8629-87679237

Accepted: 18 December 2020 Published: 31 January 2021

Citation: Zhu W, Zhao Z, Liu X, Ni X, Lei X, Li X, et al. Ginkgolide K potentiates the protective effect of ketamine against intestinal ischemia/reperfusion injury by modulating NF-κB/ERK/JNK signaling pathway. Trop J Pharm Res 2021; 20(1):11-16 doi: 10.4314/tjpr.v20i1.2

© 2021 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the effect of ginkgolide K and ketamine treatments, alone and in combination, on intestinal ischemia/reperfusion injury (I/R)-induced injury in rats, as well as the mechanism involved.

Methods: Rats were treated with ginkgolide K (GK, 15 mg/kg i.v) and ketamine (KTM, 100 mg/kg i.p.), either alone or in combination 30 min before the induction of intestinal I/R. The effects of GK and KTM were determined by assessing the levels of cytokines in serum, and parameters of oxidative stress and ROS production in the intestinal tissues of I/R rats. Moreover, intestinal mRNA expressions of JNK, ERK, p38 and NF-kB were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR).

Results: GK and KTM treatments, alone and in combination, reduced cytokine levels in serum and oxidative stress parameters in intestinal tissues, when compared to I/R group of rats. Treatments with GK and KTM, alone and in combination, mitigated the altered mRNA expressions of JNK, ERK, p38 and NF-kB in intestinal tissues of I/R-injured rats.

Conclusion: These results reveal that GK potentiates the protective effect of KTM100 on I/R-induced intestinal injury in rats by regulating the NF-kB/ERK/JNK signaling pathway. Therefore, GK and KTM may find use in the management of I/R

Keywords: Ginkgolide K, Ketamine, Intestinal injury, Ischemia/Reperfusion, Inflammation